foxo4-dri senolytic peptide human trial 2024 foxo4 dri study improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells FOXO4-DRI: The Senolytic That – Peptide Inhibitors Targeting FOXO4-p53 Interactions
Pay in 4 interest-free payments of $5.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14























